Trial Profile
Serologic Study of FluvalAB Influenza Vaccine (Trivalent, Seasonal) intended to Use in the 2009-2010 Vaccination Season
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- 08 Jun 2011 Checked vaccine name.
- 02 Jun 2011 New trial record